Iodide

Iodide

SCHEMBL7028400

CC[n+]1c(/C=C/c2ccc(N(C)C)cc2)sc2ccccc21.[I-]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
INSR P06213 18/20 0.97
APP P05067 1/20 0.84
NPC1 O15118 1/20 0.77
NSD2 O96028 1/20 0.77
MAPT P10636 1/20 0.77
THRB P10828 1/20 0.77
PKM P14618 1/20 0.77
MAPK1 P28482 1/20 0.77
HTT P42858 1/20 0.77
RAB9A P51151 1/20 0.77
KMT2A Q03164 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77
RXFP1 Q9HBX9 1/20 0.77
L3MBTL1 Q9Y468 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL29757617 1.00 INSR (0.97) INSRAPPNPC1NSD2MAPT
Iodide SCHEMBL5679445 1.00 INSR (0.97) INSRAPPNPC1NSD2MAPT
SCHEMBL9580682 0.99 INSR (1.00) INSRAPPNPC1NSD2MAPT
SCHEMBL9580683 0.99 INSR (1.00) INSRAPPNPC1NSD2MAPT
Bromide SCHEMBL22598036 0.97 INSR (0.97) INSRAPPNPC1NSD2MAPT
Bromide SCHEMBL22598035 0.97 INSR (0.97) INSRAPPNPC1NSD2MAPT
SCHEMBL2442132 0.91 APP (1.00) INSRAPPNPC1NSD2MAPT
SCHEMBL2442135 0.91 APP (1.00) INSRAPPNPC1NSD2MAPT
SCHEMBL17026625 0.90 APP (0.98) INSRAPPNPC1NSD2MAPT
SCHEMBL29409742 0.90 APP (0.98) INSRAPPNPC1NSD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6001331-A INTRODUCING INTO PATIENT BENZYLTHIAZOL-3-IUM DERIVATIVES OF GIVEN FORMULA; ALLOWING TIME FOR COMPOUND TO ASSOCIATE WITH AMYLOID; DETECTING THE LABELED COMPOUND ASSOCIATED WITH AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 1999-12-14 US claimed
WO-1997026919-A2 METHOD OF IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 1997-07-31 WO claimed
EP-0527186-A4 UNIV ILLINOIS (US) 1995-01-18 EP claimed
EP-0527186-A1 PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS The Board of Trustees for the University of Illinois (US) 1993-02-17 EP claimed
WO-1991016820-A1 PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1991-11-14 WO claimed
WO-2026102095-A1 METHODS FOR DETECTING PER- OR POLY-FLUOROALKYL SUBSTANCES WITH FLUOROPHORES UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2026-05-15 WO disclosed
EP-3478792-B1 CHEMILUMINESCENT SUBSTRATES BECKMAN COULTER INC (US) 2023-12-13 EP disclosed
US-10703971-B2 Chemiluminescent substrates BECKMAN COULTER, INC. (US) 2020-07-07 US disclosed
US-20190161675-A1 CHEMILUMINESCENT SUBSTRATES BECKMAN COULTER, INC. (US) 2019-05-30 US disclosed
EP-3478792-A1 CHEMILUMINESCENT SUBSTRATES Beckman Coulter Inc. (US) 2019-05-08 EP disclosed
WO-2018006059-A1 CHEMILUMINESCENT SUBSTRATES BECKMAN COULTER, INC. (US) 2018-01-04 WO disclosed
US-6635437-B2 Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs LUMIGEN, INC. 2003-10-21 US disclosed
EP-0613003-B1 A reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same SYSMEX CORP (JP) 2000-04-26 EP disclosed
US-6045727-A NITROGEN CONTAINING HETEROCYCLIC RING SYSTEM BEARING AN EXOCYCLIC CARBON-CARBON DOUBLE BOND. THE DOUBLE BOND IS FURTHER SUBSTITUTED AT THE DISTAL CARBON WITH A PHOSPHATE GROUP AND AN OXYGEN OR SULFUR ATOM-CONTAINING GROUP. LUMIGEN, INC. (US) 2000-04-04 US disclosed
US-6001331-A INTRODUCING INTO PATIENT BENZYLTHIAZOL-3-IUM DERIVATIVES OF GIVEN FORMULA; ALLOWING TIME FOR COMPOUND TO ASSOCIATE WITH AMYLOID; DETECTING THE LABELED COMPOUND ASSOCIATED WITH AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 1999-12-14 US disclosed
US-5891733-A COMPRISING A BUFFER AGENT, AN OSMOTIC PRESSURE COMPENSATING AGENT,A FIRST DYE WHICH IS A CONDENSED BENZENE DERIVATIVE, A SECOND FLUORESCENT DYE, AND A CHELATING AGENT TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1999-04-06 US disclosed
WO-1997026919-A2 METHOD OF IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 1997-07-31 WO disclosed
EP-0708334-A2 Reagent and method for analyzing solid components in urine TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1996-04-24 EP disclosed
US-5470751-A Reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1995-11-28 US disclosed
EP-0613003-A1 A reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1994-08-31 EP disclosed